MK-421 - A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR IN CHRONIC HEART-FAILURE - NEUROHUMORAL CORRELATES OF THE HEMODYNAMIC-RESPONSE TO ACUTE AND CHRONIC THERAPY

被引：0
|
作者：
DICARLO, L [1 ]
CHATTERJEE, K [1 ]
ATHERTON, B [1 ]
CURRAN, D [1 ]
PARMLEY, W [1 ]
机构：
[1] UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143
来源：
CLINICAL RESEARCH | 1983年 / 31卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A179 / A179
页数：1
相关论文
共 50 条
  • [31] CONCOMITANT BLOCKADE AND ACTIVATION OF THE RENIN-ALDOSTERONE SYSTEM BY AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR (MK-421) AND HYDROCHLOROTHIAZIDE
    GRIFFING, GT
    MELBY, JC
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1982, 32 (03): : 396 - 405
  • [32] ACUTE, SUBCHRONIC AND CHRONIC TOXICITY OF THE NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR RAMIPRIL
    DONAUBAUER, HH
    MAYER, D
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1988, 38-1 (01): : 14 - 20
  • [33] MK-421 - A POTENT LONG-ACTING NEW ORAL INHIBITOR OF ANGIOTENSIN CONVERTING ENZYME (ACE)
    JACKSON, B
    CUBELA, R
    JOHNSTON, CI
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1982, 9 (05) : 561 - 562
  • [34] EFFECTS IN HEALTHY-SUBJECTS OF A NEW NON-THIOL-CONTAINING ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, ENALAPRIL MALEATE (MK-421)
    NAKASHIMA, M
    NISHIJIMA, K
    CLINICAL SCIENCE, 1982, 63 : S183 - S185
  • [35] CAPTOPRIL - ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR FOR TREATMENT OF HEART-FAILURE IN MAN
    RIBNER, HS
    DAVIS, R
    LEJEMTEL, TH
    KEUNG, E
    SONNENBLICK, EH
    CLINICAL RESEARCH, 1979, 27 (02): : A199 - A199
  • [36] CENTRAL HEMODYNAMIC-RESPONSE TO EXERCISE IN PATIENTS WITH CHRONIC HEART-FAILURE
    SULLIVAN, MJ
    COBB, FR
    CHEST, 1992, 101 (05) : S340 - S346
  • [37] EFFECTS OF ENALAPRIL, A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, IN A CONTROLLED TRIAL IN HEART-FAILURE
    FRANCIOSA, JA
    WILEN, MM
    JORDAN, RA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 5 (01) : 101 - 107
  • [38] REVERSAL OF DIURETIC-INDUCED SECONDARY HYPER-ALDOSTERONISM AND HYPOKALEMIA BY ENALAPRIL (MK-421) - A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR
    GRIFFING, GT
    SINDLER, BH
    AURECCHIA, SA
    MELBY, JC
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1983, 32 (07): : 711 - 716
  • [39] SUSTAINED HEMODYNAMIC-RESPONSE TO FLOSEQUINAN IN PATIENTS WITH HEART-FAILURE RECEIVING ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS
    GOTTLIEB, SS
    KUKIN, ML
    PENN, J
    FISHER, ML
    CINES, M
    MEDINA, N
    YUSHAK, M
    TAYLOR, M
    PACKER, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (04) : 963 - 967
  • [40] EFFECTS OF A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR, ENALAPRIL, IN ACUTE AND CHRONIC LEFT-VENTRICULAR FAILURE IN DOGS
    LEDDY, CL
    WILEN, M
    FRANCIOSA, JA
    JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 23 (5-6): : 189 - 198
12345